Browse > Article

Hepatoprotective and a Potential Antiviral Effect of Biphenyl Dimethyl Dicarboxylate/Amantadine for an Acute Viral Hepatitis Induced by MHV-2 in ICR Mice  

Joo, Seong-Soo (Research Institute of Veterinary Medicine, Chungbuk National University)
Chin, Hyouk-Jun (College of Pharmacy, Chung-Ang university)
Won, Tae-Joon (College of Pharmacy, Chung-Ang university)
Jang, Su-Kil (College of Pharmacy, Chung-Ang university)
Hwang, Kwang-Woo (College of Pharmacy, Chung-Ang university)
Lee, Do-Ik (College of Pharmacy, Chung-Ang university)
Publication Information
YAKHAK HOEJI / v.51, no.3, 2007 , pp. 194-198 More about this Journal
Abstract
The mouse hepatitis virus (MHV-2) induces broad collapses, focal necrosis and cytolysis of hepatocytes, and leads to death after three to five days of intraperitoneal injection in mice. The present study investigated whether the combinatorial treatment of dimethyl dicarboxylate/amantadine (2:1) showed hepatoprotective and/or antiviral properties in MHV-2 infected ICR mice. In the study, we found that dimethyl dicarboxylate/amantadine group (VDDBA) increased the survival rate (30.8%) when compared to positive control, VL (7.7%) and that VDDBA lengthened the survival time (4.2 d)after MHV-2 infection. In addition, ALT and AST were well regulated when treated with VDDBA (p<0.01). Finally, we concluded that those results were probably from the inhibition of viral replication and at least antiproliferative effect on MHV-2.
Keywords
MHV-2; dimethyl dicarboxylate; amantadine; HBV; ICR mouse; lamivudine;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Wong, D. K., Cheung, A. M., O'Rourke, K., Naylor, C. D., Detsky, A. S. and Heathcote, J. : Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann. Intern. Med. 119, 312 (1993)
2 Pinto, L. H. and Lamb, R. A. : The M2 proton channels of influenza A and B viruses. J. Biol. Chem. 7, 8997 (2006)
3 Joo, S. S., Won, T. J., Kim, M. J., Hwang, K. W. and Lee, D. I. : Interferon signal transduction of biphenyl dimethyl dicarboxylate/ amantadine and anti-HBV activity in HepG2 2.2.15. Arch. Pharm. Res. 29, 405 (2006)   과학기술학회마을   DOI   ScienceOn
4 Seglen, P. O. : Preparation of isolated rat liver cells. Methods Cell Biol. 13, 29 (1976)
5 Matsuyama, S., Henmi, S., Ichihara, N., Sone, S., Kikuchi, T., Ariga, T. and Taguchi, F. : Protective effects of murine recombinant interferon-${\beta}$ administered by intravenous, intramuscular or subcutaneous route on mouse hepatitis virus infection. Antivir. Res. 47, 131 (2000)
6 Sun, N. and Perlman, S. : Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J. Virol. 69, 633 (1995)
7 Wang, C., Takeuchi, K., Pinto, L. and Lamb, R. A. : Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J. Virol. 67, 585 (1993)
8 Clercq, D. E. : Antiviral drugs in current clinical use. J. Clin. Virol. 30, 115 (2004)   DOI   ScienceOn
9 Liaw, Y. F., Leung, N. M., Chang, T. T., Guan, R., Tai, D. I., Ng, K. Y., Chien, R. N., Dent, J., Roman, L., Edmunson, S. and Lai, C. L. : Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia hepatitis lamivudine study group. Gastroenterology 119, 172 (2000)
10 Abe, S., Ota, Y., Koike, S., Kurata, T., Horie, H., Nomura, T., Hashizume, S. and Nomoto, A. : Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology 206, 1075 (1995)
11 Kim, S. M., Lee, K. S., Park, C. J., Lee, J. Y., Kim, K. H., Park, J. Y., Lee, J. H., Kim, H. Y., Yoo, J. Y. and Jang, M. K. : Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea. J. Infection 54, 185 (2007)   DOI   ScienceOn
12 Park, J. W. : Hepatocellular carcinoma in Korea: introduction and overview. Korean J. Gastroenterol. 45, 217 (2005)   PUBMED
13 Chisari, F. V., Ferrari, C. and Mondelli, M. U. : Hepatitis B virus structure and biology. Microb. Pathog. 6, 311 (1989)
14 Lok, A. S. : Chronic hepatitis B. Engl. J. Med. 346, 1682 (2002)   DOI   ScienceOn
15 Kang, K. W., Kim, Y. G., Kim, C. W. and Kim, S. G. : The anti-fibrogenic effect of a pharmaceutical composition of [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) and dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl- 2,2'-dicarboxylate (DDB). Arch. Pharm. Res. 25, 655 (2002)
16 Joo, S. S. and Lee, D. I. : The potential anti-HBV effect of amantadine in combination with ursodeoxycholic acid and biphenyl dimethyl dicarboxylate in HepG2 2.2.15. Arch. Pharm. Res. 28, 451 (2005)   DOI   ScienceOn
17 Fuchizaki, U., Kaneko, S., Nakamoto, Y., Sugiyama, Y., Imagawa, K., Kikuchi, M. and Kobayashi, K. : Synergistic antiviral effect of a combination of mouse interferon-alpha and interferon-gamma on mouse hepatitis virus. J. Med. Virol. 69, 188 (2003)   DOI   ScienceOn